Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. (IONS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IONS · as of Jun 8, 2026
Key Statistics
Explore Ionis Pharmaceuticals, Inc. Data
ions stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 32 · Buy rate: 62.5%
The IONS analyst consensus is Buy, based on ratings from 32 Wall Street analysts over the past 3 months. The average 12-month price target is $107.27, representing +44.03% upside from the current price of $74.48.
Competitors & Peers
ions competitorsIONS
ASND
BBIO
BMRN
EXEL
GHStock Performance
Full HistoryAbout Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSED…
what is ionis pharmaceuticals, inc. · ions stock overview · ionis pharmaceuticals, inc. company profile · who is ionis pharmaceuticals, inc. ceo · ions NASDAQ · ionis pharmaceuticals, inc. headquarters · ionis pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Ionis Pharmaceuticals, Inc. (IONS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 17, 1991. As of the latest trading session, IONS stock price is $74.48, with a market capitalization of $12.3B. The stock has returned +102.61% over the past 12 months and -5.85% year-to-date.
According to 32 Wall Street analysts, the consensus rating for Ionis Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $107.27. In fiscal year 2025, Ionis Pharmaceuticals, Inc. reported revenue of $944.0M and net income of -$381.0M. For detailed data — including Ionis Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ionis Pharmaceuticals, Inc. (IONS) stock price is $74.48. The stock is traded on NASDAQ under the ticker symbol IONS. The 52-week range is $34.78 – $86.74.